secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avidity Biosciences, Inc. (—)
CIK:        0001599901
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001599901-24-000032
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avidity Biosciences raises $400M in oversubscribed private placement; cash runway into late 2026
--------------------------------------------------------------------------------

- Gross proceeds ~$400M from sale of 15.2M shares at $16.50/share and 9.0M pre-funded warrants at $16.4990 each.
- New and existing investors include Adage Capital, Boxer Capital, Casdin, Farallon, Janus Henderson, RA Capital, RTW, Wellington.
- Placement expected to close March 4, 2024; proceeds to fund R&D, working capital, general corporate purposes.
- Pro forma cash, equivalents and investments expected to fund operations into late 2026.
- Company to host webcast March 4, 2024, to present AOC 1001 data from MARINA-OLE trial in DM1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599901/000159990124000032/0001599901-24-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599901/000159990124000032/rna-20240228.htm
  HTML page:      https://secwatch.observer/filing/0001599901-24-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer